Catalyst Wire Dossier Catalyst Wire Dossier

BREVITAL SODIUM

METHOHEXITAL SODIUM · Par Health USA, LLC
Drug timelines are a Plus or Pro feature.

6 regulatory and trial events tracked for BREVITAL SODIUM, covering 2008-05-05 to 2020-11-03. Get the full timeline:

Most recent: FDA Approved: BREVITAL SODIUM — Supplemental Application (Par Health USA, LLC)

See pricing